Name | Type | Posted | Actions |
|---|---|---|---|
Notice of Intent.pdf | May 28, 2026 |
Illumina Infinium Methylation EPIC v2.0 Kits
Contact and place of performance
David Shen
Bethesda, MD 20892
USA
Attachment: Notice of Intent
The National Institutes of Health (NIH) Office of Logistics and Acquisition Operations (OLAO) issued this pre-solicitation notice regarding the procurement of Illumina Infinium Methylation EPIC v2.0 Kits. This requirement is classified under NAICS 325414 for Biological Product (except Diagnostic) Manufacturing and PSC 6550 for In Vitro Diagnostic Substances, Reagents, Test Kits and Sets. There is no set-aside designated for this acquisition.
The procurement supports operations at the NIH facility in Bethesda, Maryland. Detailed instructions and the rationale for the acquisition are further outlined in the attached Notice of Intent document published on May 28, 2026. David Shen serves as the primary point of contact for this requirement.
The solicitation is identified by number 75N98026Q00468. Interested parties must submit responses by the deadline of June 6, 2026. Current documentation for this notice includes one attachment, a Notice of Intent PDF file.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.